Venlafaxine Besylate Patent Expiration
Venlafaxine Besylate is Used for treating depression and generalized anxiety disorder. It was first introduced by Almatica Pharma Llc
Venlafaxine Besylate Patents
Given below is the list of patents protecting Venlafaxine Besylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Venlafaxine Besylate | US7776358 | Extended release venlafaxine besylate tablets | May 16, 2028 | Almatica |
| Venlafaxine Besylate | US6717015 | Venlafaxine besylate |
Mar 27, 2023
(Expired) | Almatica |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Venlafaxine Besylate's patents.
Latest Legal Activities on Venlafaxine Besylate's Patents
Given below is the list recent legal activities going on the following patents of Venlafaxine Besylate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Feb, 2022 | US7776358 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Aug, 2018 | US7776358 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 03 Aug, 2018 | US7776358 |
| Mail O.P. Petition Decision | 02 Aug, 2018 | US7776358 |
| Email Notification Critical | 02 Aug, 2018 | US7776358 |
| Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical | 31 Jul, 2018 | US7776358 |
| Surcharge, Petition to Accept Pymt After Exp, Unintentional Critical | 30 Jul, 2018 | US7776358 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Jul, 2018 | US7776358 |
| O.P. Petition Decision | 30 Jul, 2018 | US7776358 |
| Petition Decision - Accept Late Payment of Maintenance Fees - Granted Critical | 30 Jul, 2018 | US7776358 |
Venlafaxine Besylate's Family Patents
